Abstract
The only curative treatment for end-stage liver disease is liver transplantation. However, a shortage of donor organs, financial burden on the patients, and the need for lifelong immunosuppression are major limitations. One potential solution to these issues would be to bioengineer a functioning liver from a patient's own cells in the lab, and transplant the lab-grown organ into the patient. This technology could theoretically provide unlimited grafts without the need for immunosuppression.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
